Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
27 June 2017
E-004286-17
Question for written answer
to the Commission
Rule 130
Rachida Dati (PPE)

 Subject:  Combating the sale of false medicines over the Internet
 Answer(s) 

At present, it is estimated that more than one medicine in ten worldwide is false. In Europe, the percentage of falsified medicines is close to 1%.

On the Internet, the risk of buying a falsified medicine is particularly high, as, according to the World Health Organisation, a patient runs a risk of around 50% that a medicine bought over the Internet will be falsified.

In 2011, the European Union adopted a directive on falsified medicines. Among other aspects, it regulates the sale of medicines over the Internet, and provides for awareness-raising and prevention campaigns. However, it seems that so far few campaigns have been carried out.

In view of the extent of the phenomenon, therefore, will the Commission launch a number of large-scale awareness-raising campaigns concerning the dangers of falsified medicines on the Internet?

In view of the rapid development of the Internet since 2011, what adjustments does the Commission intend to make in order to combat the sale of falsified medicines over the Internet?

Original language of question: FR 
Last updated: 13 July 2017Legal notice